IBDEI0ZT ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16154,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,16155,0)
 ;;=E05.01^^61^768^38
 ;;^UTILITY(U,$J,358.3,16155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16155,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,16155,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,16155,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,16156,0)
 ;;=E05.90^^61^768^41
 ;;^UTILITY(U,$J,358.3,16156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16156,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,16156,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,16156,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,16157,0)
 ;;=E05.91^^61^768^40
 ;;^UTILITY(U,$J,358.3,16157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16157,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,16157,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,16157,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,16158,0)
 ;;=E89.0^^61^768^32
 ;;^UTILITY(U,$J,358.3,16158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16158,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,16158,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,16158,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,16159,0)
 ;;=E03.2^^61^768^13
 ;;^UTILITY(U,$J,358.3,16159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16159,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,16159,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,16159,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,16160,0)
 ;;=E03.9^^61^768^14
 ;;^UTILITY(U,$J,358.3,16160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16160,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,16160,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,16160,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,16161,0)
 ;;=E06.0^^61^768^36
 ;;^UTILITY(U,$J,358.3,16161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16161,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,16161,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,16161,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,16162,0)
 ;;=E06.1^^61^768^37
 ;;^UTILITY(U,$J,358.3,16162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16162,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,16162,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,16162,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,16163,0)
 ;;=C73.^^61^768^19
 ;;^UTILITY(U,$J,358.3,16163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16163,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,16163,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,16163,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,16164,0)
 ;;=E16.2^^61^768^10
 ;;^UTILITY(U,$J,358.3,16164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16164,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,16164,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,16164,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,16165,0)
 ;;=E20.0^^61^768^15
 ;;^UTILITY(U,$J,358.3,16165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16165,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,16165,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,16165,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,16166,0)
 ;;=E20.9^^61^768^11
 ;;^UTILITY(U,$J,358.3,16166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16166,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,16166,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,16166,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,16167,0)
 ;;=E23.0^^61^768^12
